<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32937436</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>27</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Calpain-2 as a therapeutic target in repeated concussion-induced neuropathy and behavioral impairment.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaba5547</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.aba5547</ELocationID><Abstract><AbstractText>Repeated concussion represents a serious health problem as it can result in various brain pathologies, ranging from minor focal tissue injury to severe chronic traumatic encephalopathy. The calcium-dependent protease, calpain, participates in the development of neurodegeneration following concussion, but there is no information regarding the relative contribution of calpain-1 and calpain-2, the major calpain isoforms in the brain. We used a mouse model of repeated concussions, which reproduces most of the behavioral and neuropathological features of the human condition, to address this issue. Deletion of calpain-2 or treatment with a selective calpain-2 inhibitor for 2 weeks prevented most of these neuropathological features. Changes in TAR DNA binding protein 43 (TDP-43) subcellular localization similar to those found in human amyotrophic lateral sclerosis and frontotemporal dementia were also prevented by deletion of calpain-2 or treatment with calpain-2 inhibitor. Our results indicate that a selective calpain-2 inhibitor represents a therapeutic approach for concussion.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yubin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8836-9632</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8137-9320</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nham</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherbaf</LastName><ForeName>Arash</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3808-4038</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quach</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahya</LastName><ForeName>Emad</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3397-3434</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranburger</LastName><ForeName>Davis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9457-9049</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Xiaoning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baudry</LastName><ForeName>Michel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5142-241X</Identifier><AffiliationInfo><Affiliation>Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA. mbaudry@westernu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D002154">Calpain</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001924" MajorTopicYN="Y">Brain Concussion</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002154" MajorTopicYN="Y">Calpain</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32937436</ArticleId><ArticleId IdType="pmc">PMC7458466</ArticleId><ArticleId IdType="doi">10.1126/sciadv.aba5547</ArticleId><ArticleId IdType="pii">6/27/eaba5547</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hiskens M. I., Angoa-P&#xe9;rez M., Schneiders A. G., Vella R. K., Fenning A. S., Modeling sports-related mild traumatic brain injury in animals-A systematic review. J. Neurosci. Res. 97, 1194&#x2013;1222 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31135069</ArticleId></ArticleIdList></Reference><Reference><Citation>Siedler D. G., Chuah M. I., Kirkcaldie M., Vickers J. C., King A. E., Diffuse axonal injury in brain trauma: Insights from alterations in neurofilaments. Front. Cell. Neurosci. 8, 429 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269130</ArticleId><ArticleId IdType="pubmed">25565963</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Sen N., Traumatic brain injury: A risk factor for neurodegenerative diseases. Rev. Neurosci. 27, 93&#x2013;100 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26352199</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elfattah Foda M. A., Marmarou A., A new model of diffuse brain injury in rats. Part II: Morphological characterization. J. Neurosurg. 80, 301&#x2013;313 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8283270</ArticleId></ArticleIdList></Reference><Reference><Citation>Fesharaki-Zadeh A., Chronic Traumatic Encephalopathy: A brief overview. Front. Neurol. 10, 713 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6616127</ArticleId><ArticleId IdType="pubmed">31333567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosler P. S., Sun D., Wang S., Gao Y., Kintner D. B., Signore A. P., Cao G., Chen J., Calcium dysregulation induces apoptosis-inducing factor release: Cross-talk between PARP-1- and calpain-signaling pathways. Exp. Neurol. 218, 213&#x2013;220 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710414</ArticleId><ArticleId IdType="pubmed">19427306</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz-Unal A., Korulu S., Karabay A., Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis. Treat. 11, 297 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4327398</ArticleId><ArticleId IdType="pubmed">25709452</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumura A., Nonaka Y., Hyakkoku K., Oka T., Shimazawa M., Hozumi I., Inuzuka T., Hara H., A novel calpain inhibitor,((1S)-1 ((((1S)-1-benzyl-3-cyclopropylamino-2, 3-di-oxopropyl) amino) carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. Neuroscience 157, 309&#x2013;318 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18835333</ArticleId></ArticleIdList></Reference><Reference><Citation>Anagli J., Han Y., Stewart L., Yang D., Movsisyan A., Abounit K., Seyfried D., A novel calpastatin-based inhibitor improves postischemic neurological recovery. Biochem. Biophys. Res. Commun. 385, 94&#x2013;99 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19422795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Yin F., Zhang J., Qian Y., The role of calpains in traumatic brain injury. Brain Inj. 28, 133&#x2013;137 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24456052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobeissy F. H., Liu M. C., Yang Z., Zhang Z., Zheng W., Glushakova O., Mondello S., Anagli J., Hayes R. L., Wang K. K., Degradation of &#x3b2;II-spectrin protein by calpain-2 and caspase-3 under neurotoxic and traumatic brain injury conditions. Mol. Neurobiol. 52, 696&#x2013;709 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383741</ArticleId><ArticleId IdType="pubmed">25270371</ArticleId></ArticleIdList></Reference><Reference><Citation>E. B. Cagmat, J. D. Guingab-Cagmat, A. V. Vakulenko, R. L. Hayes, J. Anagli, Potential Use of Calpain Inhibitors as Brain Injury Therapy. in Brain Neurotrauma: Molecular, Neuropsychological and Rehabilitation Aspects, F. H. Kobeissy, Ed. (CRC Press/Taylor &amp; Francis, 2015), Chapter 40.</Citation></Reference><Reference><Citation>Siklos M., BenAissa M., Thatcher G. R. J., Cysteine proteases as therapeutic targets: Does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm. Sin. B 5, 506&#x2013;519 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4675809</ArticleId><ArticleId IdType="pubmed">26713267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono Y., Saido T. C., Sorimachi H., Calpain research for drug discovery: Challenges and potential. Nat. Rev. Drug Discov. 15, 854&#x2013;876 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27833121</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson S. N., Carrico K. M., Mustafa A. G., Bains M., Hall E. D., A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J. Neurotrauma 27, 2233&#x2013;2243 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996835</ArticleId><ArticleId IdType="pubmed">20874056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X.-X., Jeromin A., Spectrin breakdown products (SBDPs) as potential biomarkers for neurodegenerative diseases. Curr. Transl. Geriatr. Exp. Gerontol. Rep. 1, 85&#x2013;93 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661686</ArticleId><ArticleId IdType="pubmed">23710421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch K. M., Reyn C. R., Bian J., Telling G. C., Meaney D. F., Saatman K. E., Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse. J. Neurochem. 125, 909&#x2013;920 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676438</ArticleId><ArticleId IdType="pubmed">23305291</ArticleId></ArticleIdList></Reference><Reference><Citation>Bains M., Cebak J. E., Gilmer L. K., Barnes C. C., Thompson S. N., Geddes J. W., Hall E. D., Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model. J. Neurochem. 125, 125&#x2013;132 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23216523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill C. S., Coleman M. P., Menon D. K., Traumatic axonal injury: Mechanisms and translational opportunities. Trends Neurosci. 39, 311&#x2013;324 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405046</ArticleId><ArticleId IdType="pubmed">27040729</ArticleId></ArticleIdList></Reference><Reference><Citation>Siman R., Giovannone N., Hanten G., Wilde E. A., McCauley S. R., Hunter J. V., Li X., Levin H. S., Smith D. H., Evidence that the blood biomarker SNTF predicts brain imaging changes and persistent cognitive dysfunction in mild TBI patients. Front. Neurol. 4, 190 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831148</ArticleId><ArticleId IdType="pubmed">24302918</ArticleId></ArticleIdList></Reference><Reference><Citation>Siman R., Shahim P., Tegner Y., Blennow K., Zetterberg H., Smith D. H., Serum SNTF increases in concussed professional ice hockey players and relates to the severity of postconcussion symptoms. J. Neurotrauma 32, 1294&#x2013;1300 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4543483</ArticleId><ArticleId IdType="pubmed">25419578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu Y., Lopez D., Lee M., Dayal S., Hurtado A., Bi X., Baudry M., Protection against TBI-induced neuronal death with post-treatment with a selective calpain-2 inhibitor in mice. J. Neurotrauma 35, 105&#x2013;117 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5757088</ArticleId><ArticleId IdType="pubmed">28594313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Briz V., Chishti A., Bi X., Baudry M., Distinct roles for &#x3bc;-calpain and M-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. J. Neurosci. 33, 18880&#x2013;18892 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3841454</ArticleId><ArticleId IdType="pubmed">24285894</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez E. J., Tapanes S. A., Loris Z. B., Balu D. T., Sick T. J., Coyle J. T., Liebl D. J., Enhanced astrocytic D-serine underlies synaptic damage after traumatic brain injury. J. Clin. Invest. 127, 3114&#x2013;3125 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5531405</ArticleId><ArticleId IdType="pubmed">28714867</ArticleId></ArticleIdList></Reference><Reference><Citation>Petraglia A. L., Plog B. A., Dayawansa S., Chen M., Dashnaw M. L., Czerniecka K., Walker C. T., Viterise T., Hyrien O., Iliff J. J., Deane R., Nedergaard M., Huang J. H., The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: A novel mouse model of chronic traumatic encephalopathy. J. Neurotrauma 31, 1211&#x2013;1224 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082360</ArticleId><ArticleId IdType="pubmed">24766454</ArticleId></ArticleIdList></Reference><Reference><Citation>Petraglia A. L., Plog B. A., Dayawansa S., Dashnaw M. L., Czerniecka K., Walker C. T., Chen M., Hyrien O., Iliff J. J., Deane R., Huang J. H., Nedergaard M., The pathophysiology underlying repetitive mild traumatic brain injury in a novel mouse model of chronic traumatic encephalopathy. Surg. Neurol. Int. 5, 184 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287910</ArticleId><ArticleId IdType="pubmed">25593768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaan N. M., Morfini G. A., LaPointe N. E., Pigino G. F., Patterson K. R., Song Y., Andreadis A., Fu Y., Brady S. T., Binder L. I., Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 31, 9858&#x2013;9868 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391724</ArticleId><ArticleId IdType="pubmed">21734277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaan N. M., Cox K., Alvarez V. E., Stein T. D., Poncil S., McKee A. C., Characterization of early pathological tau conformations and phosphorylation in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 75, 19&#x2013;34 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891281</ArticleId><ArticleId IdType="pubmed">26671985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X., Yu J., Huang S., Yin Z., Han Z., Chen F., Wang Z., Zhang J., Lei P., A novel repetitive mild traumatic brain injury mouse model for chronic traumatic encephalopathy research. J. Neurosci. Methods 308, 162&#x2013;172 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30076860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin A. S., Lee V. M.-Y., Trojanowski J. Q., TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6, 211&#x2013;220 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Hideyama T., Hachiga K., Teramoto S., Takano J., Iwata N., Saido T. C., Kwak S., A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 3, 1307 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhu G., Briz V., Hsu Y.-T., Bi X., Baudry M., A molecular brake controls the magnitude of long-term potentiation. Nat. Commun. 5, 3051 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3895372</ArticleId><ArticleId IdType="pubmed">24394804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmsson U., Bushong E. A., Price D. L., Smarr B. L., Phung V., Terada M., Ellisman M. H., Pekny M., Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. U.S.A. 103, 17513&#x2013;17518 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1859960</ArticleId><ArticleId IdType="pubmed">17090684</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis B. M., Salinas-Navarro M., Cordeiro M. F., Moons L., De Groef L., Characterizing microglia activation: A spatial statistics approach to maximize information extraction. Sci. Rep. 7, 1576&#x2013;1512 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5431479</ArticleId><ArticleId IdType="pubmed">28484229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouzon B. C., Bachmeier C., Ferro A., Ojo J. O., Crynen G., Acker C. M., Davies P., Mullan M., Stewart W., Crawford F., Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann. Neurol. 75, 241&#x2013;254 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24243523</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson J. E., Sengupta U., Kayed R., Tau oligomers as pathogenic seeds: Preparation and propagation in vitro and in vivo. Methods Mol. Biol. 1523, 141&#x2013;157 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27975249</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Li J., Zheng J., Qin S., Reactive astrocytes in neurodegenerative diseases. Aging Dis. 10, 664&#x2013;675 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538217</ArticleId><ArticleId IdType="pubmed">31165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Hall R. A., Lee M., Kamgar-Parsi A., Bi X., Baudry M., The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation. Sci. Rep. 7, 11771 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5603515</ArticleId><ArticleId IdType="pubmed">28924170</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarjov M., Ahmad F., Kaila K., Blaesse P., Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain. J. Neurosci. 32, 11356&#x2013;11364 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6621186</ArticleId><ArticleId IdType="pubmed">22895718</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgoraptis N., Li L. M., Whittington A., Zimmerman K. A., Maclean L. M., McLeod C., Ross E., Heslegrave A., Zetterberg H., Passchier J., Matthews P. M., Gunn R. N., McMillan T. M., Sharp D. J., In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury. Sci. Transl. Med. 11, eaaw1993 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31484787</ArticleId></ArticleIdList></Reference><Reference><Citation>Walf A. A., Frye C. A., The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322&#x2013;328 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3623971</ArticleId><ArticleId IdType="pubmed">17406592</ArticleId></ArticleIdList></Reference><Reference><Citation>Can A., Dao D. T., Terrillion C. E., Piantadosi S. C., Bhat S., Gould T. D., The tail suspension test. J. Vis. Exp. 2012, e3769 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3353516</ArticleId><ArticleId IdType="pubmed">22315011</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sun J., Wang Y., Lopez D., Tran J., Bi X., Baudry M., Deleting both PHLPP1 and CANP1 rescues impairments in long-term potentiation and learning in both single gene knock-out mice. Learn. Mem. 23, 399&#x2013;404 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947237</ArticleId><ArticleId IdType="pubmed">27421891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>